Characteristics and potential quality indicators for evaluating pre-travel consultations in Japan hospitals: the Japan Pretravel consultation registry (J-PRECOR).

Autor: Yamamoto K; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan. kyamamoto@hosp.ncgm.go.jp., Asai Y; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan., Nakatani I; Travel Clinic, Nara Seibu Hospital, Nara, Japan., Hayashi K; Department of Infectious Diseases, Kenwakai Otemachi Hospital, Kitakyushu, Japan., Nakagawa H; Department of Infectious Diseases, Osaka City General Hospital, Osaka, Japan., Shinohara K; Department of Infectious Diseases, Kyoto City Hospital, Kyoto, Japan., Kanai S; Department of Infection Control, Shinshu University Hospital, Matsumoto, Japan., Shimatani M; Department of Infectious Diseases, Hamamatsu Medical Center, Hamamatsu, Japan., Yamato M; Department of General Medicine and Infectious Diseases, Travel Clinic, Rinku General Medical Center, Izumisano, Japan., Shimono N; Center for the Study of Global Infection, Kyushu University Hospital, Fukuoka, Japan., Kitaura T; Center for Infectious Disease, Tottori University Hospital, Yonago, Japan., Komiya N; Department of Infectious Diseases, Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan., Nagasaka A; Department of Infectious Diseases, Sapporo City General Hospital, Sapporo, Japan., Mikawa T; Department of General Medicine and Infectious Diseases, Yamanashi Prefectural Central Hospital, Kofu, Japan., Manabe A; Department of Clinical Laboratory Medicine, Fukuyama City Hospital, Fukuyama, Japan., Matono T; Department of Infectious Diseases, Aso Iizuka Hospital, Iizuka, Japan., Yamamoto Y; Department of Clinical Infectious Diseases, Toyama University Hospital, Toyama, Japan., Ogawa T; Center for Infectious Diseases, Nara Medical University Hospital, Kashihara, Japan., Kutsuna S; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan., Ohmagari N; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
Jazyk: angličtina
Zdroj: Tropical diseases, travel medicine and vaccines [Trop Dis Travel Med Vaccines] 2022 Feb 01; Vol. 8 (1), pp. 6. Date of Electronic Publication: 2022 Feb 01.
DOI: 10.1186/s40794-021-00160-4
Abstrakt: Background: Awareness of pre-travel consultations (PTCs) and prevention methods for overseas travel-related diseases, and the understanding of PTCs among Japanese travelers and medical professionals remains low in Japan. A multicenter registry was established to examine PTCs in Japan. This study assessed the PTC implementation rate and examined the indicators of PTCs that can be used as criteria for evaluating quality.
Methods: Clients who presented for their PTCs at 17 facilities and were registered between February 1, 2018, and May 31, 2020, were included. Medical information was extracted retrospectively via a web-based system. Correlations between vaccination risk categories and advice/intervention proportions by the facility were evaluated using Spearman's ordered phase relations (α = 0.05).
Results: Of the 9700 eligible clients (median age, 32 years; 880 [9.1%] aged < 16 years and 549 [5.7%] aged ≥65 years), the most common travel duration was ≥181 days (35.8%); higher among younger clients. The most common reason for travel was business (40.5%); the US (1118 [11.5%]) and Asia (4008 [41.3%]) were the most common destinations and continents, respectively. The vaccine number (median three per person) increased after the PTCs except for the tetanus toxoid. Only 60.8% of the clients recommended for malaria prophylaxis received anti-malarial agents. The gross national income; the incidence of human rabies, typhoid fever, falciparum malaria; and dengue risk category were associated with the percentage of hepatitis-A vaccines; explaining rabies post-exposure prophylaxis, typhoid-fever vaccinations, malaria-prophylaxis prescriptions; and mosquito repellants, respectively.
Conclusions: Although the characteristics of the travelers differed, the quality of the PTCs should be improved to address, for example, the lower rate of acceptance of malaria prophylaxis in Japan.
(© 2022. The Author(s).)
Databáze: MEDLINE